| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $983,775 ) |
| | 2023 | 2023 | PRIMORDIAL GENETICS, INC. | 3550 GENERAL ATOMICS COURT MS G02 400 | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R44HG010995 | DNA 3.0: Development of a novel, efficient and cost-effective enzymatic process for synthesis of DNA oligonucleotides | 000 | 3 | NIH | 4/26/2023 | $983,775 |
| | 2023 | 2021 | PRIMORDIAL GENETICS, INC. | 3550 GENERAL ATOMICS COURT MS G02 400 | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R44GM131548 | Development of superior polymerases for next-generation mRNA therapeutic & vaccine manufacturing | 001 | 3 | NIH | 12/26/2022 | $0 |
| | 2023 | 2021 | PRIMORDIAL GENETICS, INC. | 3550 GENERAL ATOMICS COURT MS G02 400 | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R44GM131548 | Development of superior polymerases for next-generation mRNA therapeutic & vaccine manufacturing | 002 | 3 | NIH | 9/28/2023 | $0 |
| | 2023 | 2020 | PRIMORDIAL GENETICS, INC. | 3550 GENERAL ATOMICS COURT MS G02 400 | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R43HG010995 | DNA 3.0: Developing novel enzymes for DNA synthesis with deep learning and combinatorial genetics | 000 | 1 | NIH | 4/24/2023 | $0 |
| | 2023 | 2020 | PRIMORDIAL GENETICS, INC. | 3550 GENERAL ATOMICS COURT MS G02 400 | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R44GM131548 | Development of superior polymerases for next-generation mRNA therapeutic & vaccine manufacturing | 000 | 2 | NIH | 12/23/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $1,059,968 ) |
| | 2022 | 2022 | PRIMORDIAL GENETICS, INC. | 3550 GENERAL ATOMICS COURT MS G02 400 | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R44HG010995 | DNA 3.0: Development of a novel, efficient and cost-effective enzymatic process for synthesis of DNA oligonucleotides | 000 | 2 | NIH | 4/26/2022 | $1,059,968 |
|
| Issue Date FY: 2021 ( Subtotal = $521,286 ) |
| | 2021 | 2021 | PRIMORDIAL GENETICS, INC. | 3550 GENERAL ATOMICS COURT MS G02 400 | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R44GM131548 | Development of superior polymerases for next-generation mRNA therapeutic & vaccine manufacturing | 000 | 3 | NIH | 8/5/2021 | $469,286 |
| | 2021 | 2021 | PRIMORDIAL GENETICS, INC. | 3550 GENERAL ATOMICS COURT MS G02 400 | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R43HG010995 | DNA 3.0: Developing novel enzymes for DNA synthesis with deep learning and combinatorial genetics | 002 | 1 | NIH | 5/14/2021 | $0 |
| | 2021 | 2021 | PRIMORDIAL GENETICS, INC. | 3550 GENERAL ATOMICS COURT MS G02 400 | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R43HG010995 | DNA 3.0: Developing novel enzymes for DNA synthesis with deep learning and combinatorial genetics | 000 | 1 | NIH | 3/17/2021 | $52,000 |
| | 2021 | 2020 | PRIMORDIAL GENETICS, INC. | 3550 GENERAL ATOMICS COURT MS G02 400 | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R43HG010995 | DNA 3.0: Developing novel enzymes for DNA synthesis with deep learning and combinatorial genetics | 001 | 1 | NIH | 3/26/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,526,571 ) |
| | 2020 | 2020 | PRIMORDIAL GENETICS, INC. | 3550 GENERAL ATOMICS COURT MS G02 400 | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R43HG010995 | DNA 3.0: Developing novel enzymes for DNA synthesis with deep learning and combinatorial genetics | 000 | 1 | NIH | 4/9/2020 | $374,524 |
| | 2020 | 2020 | PRIMORDIAL GENETICS, INC. | 3550 GENERAL ATOMICS COURT MS G02 400 | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R44GM131548 | Development of superior polymerases for next-generation mRNA therapeutic & vaccine manufacturing | 000 | 2 | NIH | 8/5/2020 | $1,152,047 |
| | 2020 | 2018 | PRIMORDIAL GENETICS, INC. | 3550 GENERAL ATOMICS COURT MS G02 400 | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R43GM131548 | Discovery and development of single-subunit RNA polymerases for efficient RNA manufacturing | 000 | 1 | NIH | 11/16/2019 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2018 | PRIMORDIAL GENETICS INC. | 3550 GENERAL ATOMICS COURT MS G02 400 | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R43GM126828 | Synthetic biology E. coli strain development for expression of functional human GPCRs with roles in human disease | 000 | 1 | NIH | 12/14/2018 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $449,915 ) |
| | 2018 | 2018 | PRIMORDIAL GENETICS INC. | 3550 GENERAL ATOMICS COURT MS G02 400 | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R43GM131548 | Discovery and development of single-subunit RNA polymerases for efficient RNA manufacturing | 000 | 1 | NIH | 9/14/2018 | $224,963 |
| | 2018 | 2018 | PRIMORDIAL GENETICS INC. | 3550 GENERAL ATOMICS COURT MS G02 400 | SAN DIEGO | CA | 92121-1122 | SAN DIEGO | USA | R43GM126828 | Synthetic biology E. coli strain development for expression of functional human GPCRs with roles in human disease | 000 | 1 | NIH | 12/25/2017 | $224,952 |
|
|
